Wednesday, April 1, 2020

Aspen Neuroscience Gets $70M

San Diego-based Aspen Neuroscience, a biotechnology company developing treatments for Parkinson disease, said it has raised $70M in a Series A funding round. The funding was led by OrbiMed, and also included ARCH Venture Partners, Frazier Healthcare Partners, Domain Associates, Section 32, and Sam Altman. The company, led by CEO Dr. Howard Fede

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.